Skip to main content

and
  1. Article

    Open Access

    OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients

    Nowadays, evaluation of the efficacy and the duration of treatment, in context of monitoring patients with solid tumors, is based on the RECIST methodology. With these criteria, resistance and/or insensitivity...

    Sébastien Vachenc, Jessica Gobbo, Sarah El Moujarrebe, Isabelle Desmoulins in BMC Cancer (2022)

  2. Article

    Open Access

    Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection

    A better understanding of the molecular profile of anal squamous cell carcinomas (ASCCs) is necessary to consider new therapeutic approaches, and the identification of prognostic and predictive factors for res...

    Wulfran Cacheux, Etienne Rouleau, Adrien Briaux in British Journal of Cancer (2016)

  3. Article

    Open Access

    Small bowel adenocarcinoma phenoty**, a clinicobiological prognostic study

    Small bowel adenocarcinoma (SBA) is a rare tumour with a poor prognosis. Molecular biology data on SBA carcinogenesis are lacking.

    T Aparicio, M Svrcek, A Zaanan, E Beohou, A Laforest in British Journal of Cancer (2013)

  4. Article

    Open Access

    Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

    The anti-VEGF antibody bevacizumab associated with an irinotecan or oxaliplatin-based chemotherapy was proved to be superior to the chemotherapy alone in first or second line treatment of metastatic colorectal...

    Astrid Lièvre, Emmanuelle Samalin, Emmanuel Mitry, Eric Assenat in BMC Cancer (2009)